Former National Basketball Association (NBA) star Shawn Kemp is opening Seattle, Washington’s first Black-owned cannabis dispensary on October 30. Kemp, drafted by the Seattle Supersonics in the first round of the 1989 draft, played for the team until 1997 and was a six-time NBA All-Star and three-time All-NBA selection.

Pharmather is seeking to advance a ketamine-based therapy for the treatment of Parkinson’s disease.

Missouri’s medical cannabis market launched over the weekend, with a pair of retail outlets outside St. Louis seeing long patient lines in a state where MMJ sales could hit an estimated $650 million a year by 2024.

The business outlook for cannabis companies could be significantly different this time next year, depending in large part on which party controls the Senate and which senators are elected.

The latest psychedelic drug company to commence public trading is Psyched Wellness.

An enormous Crisis. Huge treatment markets. Massive disruption potential. Welcome to the psychedelic drug industry.

Field Trip Health opens a new clinic in Chicago, its 4th ketamine-assisted psychotherapy clinic.

Numinus announces its first psilocybin harvest and the appointment of a new Science Officer.

As they respond to the 2019 vaping health crisis, Colorado marijuana regulators are believed to be among the first in the nation to require cannabis vaporizer companies to test the aerosol produced when the oil is heated into vapor.

A coalition of state and local marijuana regulators sent a letter to House leadership on Wednesday, demanding that they prioritize a marijuana legalization bill that’s expected to get a floor vote following the election.